TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Inhalation Sciences Sweden AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,578
|
1,096
|
921 |
| Financial expenses |
90
|
9
|
4 |
| Earnings before taxes |
-428
|
-1,090
|
-1,624 |
| EBITDA |
-238
|
-975
|
-1,505 |
| Total assets |
1,637
|
1,167
|
2,553 |
| Current assets |
1,423
|
853
|
2,101 |
| Current liabilities |
430
|
411
|
495 |
| Equity capital |
1,167
|
679
|
1,924 |
| - share capital |
547
|
409
|
445 |
| Employees (average) |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.3%
|
58.2%
|
75.4% |
| Turnover per employee |
197
|
122
|
102 |
| Profit as a percentage of turnover |
-27.1%
|
-99.5%
|
-176.3% |
| Return on assets (ROA) |
-20.6%
|
-92.6%
|
-63.5% |
| Current ratio |
330.9%
|
207.5%
|
424.4% |
| Return on equity (ROE) |
-36.7%
|
-160.5%
|
-84.4% |
| Change turnover |
479
|
249
|
-70 |
| Change turnover % |
44%
|
29%
|
-7% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.